#troponin test kits

[recombigenlabs]

Troponin I Test Kit Manufacturer & Supplier

Get the best quotation & pricing for Troponin - I Test Kits manufactured by Recombigen Laboratories.

Buy Now: Troponin I Test

Enquire Now for Bulk Orders

[balrajgis]

Cardiac Marker Testing Market worth USD 10.5 billion by 2031 | Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany)

The global cardiac marker testing market was valued at USD 3.9 billion in 2021 and it is anticipated to grow at 10.4% CAGR during the forecast period to reach up to USD 10.5 billion by 2031.

Global Cardiac Marker Testing Market report from Global Insight Services is the single authoritative source of intelligence on Cardiac Marker Testing Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Cardiac markers are utilized in the treatment and risk stratification of patients with the suspected coronary acute syndrome (ACS). Troponin I and T, HDCRP, myoglobin, CK-MB, and other cardiac marker tests are among the most common. When the heart is stressed or injured, substances called cardiac markers are released into the blood. Hormones, enzymes, and proteins are examples of these markers. These biomarkers can be helpful to detect a variety of heart disorders, comprising acute coronary syndrome, cardiac ischemia, and conditions involving obstructed blood flow to the heart.

To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS10254/

Market Trends and Drivers

The key factor boosting the growth of the market is the growing incidence of cardiovascular diseases. The prevalence of lifestyle diseases such as hypertension, obesity, dyslipidemia, and diabetes, which are major risk factors for CVD, is also on the rise. In 2016, more than 1.9 billion adults globally were overweight; of these, over 600 million people were obese. It is anticipated that ~41% of the world’s population will be overweight or obese by 2030. The association between obesity and the risk of coronary heart disease was published by investigators (Bogers RP, Bemelmans WJ, Hogeveen RT, et al.) by a meta-analysis of 21 long-term studies conducted by them with more than 300,000 participants. It was witnessed that participants who were overweight had a 32% higher risk of developing coronary artery disease (CAD), and those who were obese had an 81% higher risk as compared with participants who were a normal weight.

Market Segments

By Product

Reagents & Kits

Instruments

By Biomarker Type

Troponin I and T

CK-MB

Bnp or Nt-Probnp

By Disease

Myocardial Infarction

Congestive Heart Failure

Acute Coronary Syndrome

By End User

Laboratory Testing

Academic Institutes

Point of Care Testing Facilities

By Region

North AmericaThe U.S.

Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS10254

Key Players

Roche Diagnostics Ltd. (Switzerland)

Abbott Laboratories (US)

Siemens Healthineers AG (Germany)

Danaher Corporation (US)

bioMérieux SA (France)

LSI Medience Corporation (Japan)

Ortho Clinical Diagnostics (US)

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Excel data pack included with all report purchases

Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[1market]

Cardiac Biomarker Diagnostic Kits Market Market: Growth, Trends, Future Opportunities, Analysis and Forecast To 2025 |Research Informatic

Global Cardiac Biomarker Diagnostic Kits Market

Market Overview

Cardiac biomarkers like enzymes, hormones, and proteins are delivered into the blood in conditions when the heart is anxious or harmed. Cardiac biomarkers are utilized to assess the heart capacity of patients with chest torment and suspected intense coronary disorder. Cardiac Biomarker Diagnostic Kits assume a basic part in the early discovery or expectation of heart-related diseases.

In the emergency and the executives of the scope of heart-related conditions, Cardiac biomarkers are required, where time delay altogether affects the short and longer-term results of a patient. Conditions that can be analyzed incorporate myocardial localized necrosis, respiratory failure, intense coronary disorder, or ACS, among others.

Get Sample PDF Copy: https://www.researchinformatic.com/sample-request/205

Market Segmentation

The global Cardiac Biomarker Diagnostic Kits market can be segmented into Anatomy, Drug Type, Route of Administration, Purchasing Pattern, and Distribution Channel.

Based on type, the cardiac biomarkers market is segmented into

·         Creatine kinase(CK-MB), 

·         Troponins T and I, 

·         Myoglobin, 

·         B-type natriuretic peptide (BNP), 

·         N-terminal prob-type natriuretic peptide (NT-proBNP), 

·         Ischemia-modified albumin (IMA), and others. 

Based on product, the market is segmented into 

·         Reagents and Kits, 

·         Instruments, 

·         Chemiluminescence, 

·         Immunofluorescence, 

·         Elisa, and Immunochromatography. 

  Based on disease, the market is segmented into 

·         Myocardial Infarction, 

·         Congestive Heart Failure. 

  Based on testing type, the market is segmented into 

·         Laboratory Testing,

·         Point-Of-Care Testing. 

 Check available discounts on this report:  https://www.researchinformatic.com/discount-205

Regional Analysis

North America is anticipated to lead the market during the forecast period. The growth of the market can be attributed to the increasing number of obesity cases and the significant rise in obesity cases. According to United Nations World Population Ageing 2019 Report, in the United States, the number of people 65 years of age is expected to reach 70.842 million by 2032. Further, increasing research and development activities in the development of novel therapeutics in the North American region is projected to be another salient cause bolstering the industry in the forecast period. For instance, in March 2019, Fidia Pharma USA Inc. obtained FDA's approval for TRILURON, which is a hyaluronic acid (HA) based intra-articular viscosupplement indicated for the treatment of knee pain in Cardiac Biomarker Diagnostic Kits. Owing to the aforementioned factors, the market in North America is expected to lead the industry in the forecast period.

Do You Have Any Query or Specific Requirement? Ask Our Industry Expert: https://www.researchinformatic.com/inquiry/205

Competitive Landscape

Key players of the global Cardiac Biomarker Diagnostic Kits market include

·         Beckman Coulter

·         bioMérieux SA

·         Philips

·         Abbott Laboratories

·         Olympus Corporation

·         Siemens Healthcare GmbH

·         Johnson and Johnson

·         Hoffmann-La Roche Ltd.

·         Tosoh Corporation

·         PerkinElmer Inc.

 Some of the recent developments are:

·         In February 2020, Anika Therapeutics Inc. acquired Arthosurface, which resulted in the growth of the joint preservation and restoration product portfolio.

·         In December 2020, Moebius Medical received FDA clearance for its investigational new drug application to start a global multi-center Phase LLB clinical trial of MM-II. It is a novel candidate for treatment for pain due to knee Cardiac Biomarker Diagnostic Kits.

Key Benefits of the report-:

 1. Reveals insight into the restrictions present in the worldwide Cardiac Biomarker Diagnostic Kits Market that can hamper the development of the market in the coming years. 

 2. The report introduces a reasonable focus on how these limitations can be transformed into circumstances when surveyed appropriately.

 3. Developing ways of life, tax collection arrangements, and buying forces of different economies have been examined in Cardiac Biomarker Diagnostic Kits Market incredible detail. 

4. Displays generation and income estimates for the worldwide market, creation and utilization estimates for local needs, output, income, and value figures for the worldwide Cardiac Biomarker Diagnostic Kits Market.

 5. Offers a forward-looking point of view of the Cardiac Biomarker Diagnostic Kits Market by giving nitty-gritty insights giving brisk data about the market's general advancement throughout the conjecture time frame.

 6. Improves decision-making capabilities by presenting accurate to an extended picture of this vast Cardiac Biomarker Diagnostic Kits Market.

 Get Your Customised Research Report: https://www.researchinformatic.com/request-customization-205

 Some Points from Table of Contents of Global Cardiac Biomarker Diagnostic Kits Market:

 Chapter 1 Cardiac Biomarker Diagnostic Kits Market Overview

1.1 Product Overview and Scope of Cardiac Biomarker Diagnostic Kits

1.2 Cardiac Biomarker Diagnostic Kits Market Segmentation By Type

1.2.1 Creatine Kinase (CK-MB),

1.2.2 Troponins T And I,

1.2.3 B-Type Natriuretic Peptide (BNP),

1.2.4 N-Terminal Prob-Type Natriuretic Peptide (NT-Probnp),

  1.2.5 Ischemia-Modified Albumin (IMA)

1.3 Cardiac Biomarker Diagnostic Kits Market Segmentation by Applications

1.3.1 Reagents and Kits,

1.3.2 Instruments,

1.3.3 Chemiluminescence

1.3.4 Immunofluorescence,

1.3.5 Elisa, and Immunochromatography

1.4 Cardiac Biomarker Diagnostic Kits Market Segmentation by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

1.5 Global Market Size (Value) of Cardiac Biomarker Diagnostic Kits (2015-2027)

Chapter 2 Global Economic Impact on Cardiac Biomarker Diagnostic Kits Industry

2.1 Global Macroeconomic Environment Analysis

2.1.1 Global Macroeconomic Analysis

2.1.2 Global Macroeconomic Environment Development Trend

2.2 Global Macroeconomic Environment Analysis by Regions

 Chapter 3 Global Cardiac Biomarker Diagnostic Kits Market Competition by Manufacturers

 TOC Continued……

 Browse In-depth Research Informatic Report (250 Pages) on Cardiac Biomarker Diagnostic Kits Market @    https://www.researchinformatic.com/reports/cardiac-biomarker-diagnostic-kits-market/205

Check out more studies related Reports, published by Research Informatic:

·         Animal Ultrasound Market Size, Share, Growth | Industry Forecast Report, 2026

·         Health Data Archiving Market Size, Share, Growth | Industry Forecast Report, 2026

·         DNA Origami Market Size, Share, Growth | Industry Forecast Report, 2026

About Us:

Research Informatic is a bulging market research and consultancy company based in Nevada, United States, with a report distribution center in India. We are committed to assisting our clients in making critical business decisions by fulfilling their niche market research needs. Our clients are spread across more than 130 countries and in all business domains. Our service offerings include syndicated research, tailored research, consumer surveys, and consulting. We concentrate on making investment decisions based on a variety of criteria such as growth size, benefits strategies, technical advances, and changing consumer inclinations, to name a few.

Our syndicated and custom research reports assist our customers in growing their businesses across a broad range of industries. In the fields of healthcare, chemicals and materials, ICT, Automation, Semiconductors & Electronics, Consumer goods, Energy, Food & Beverages, and Packaging, we include research studies in the form of syndicate reports, custom reports, market surveys, and consultancy projects.

Contact Us:

George Miller

1887 Whitney Mesa

Dr. Henderson, NV 89014

+1 775 237 4147

sales@researchinformatic.com

https://researchinformatic.com

Web: https://www.researchinformatic.com/categories/life-science

Follow us on LinkedIn:https://www.linkedin.com/company/research-informatic/mycompany/

 Have a look at our Related Articles:

 2.2 million Indian accounts Banned by What'sapp. - NUNewsIndustry

 Wharton School Will Accept Cryptocurrency As Payment Method

Facebook is investing $150 million into virtual reality  - NUNewsIndustry

 Facebook rebrands itself to 'Meta' - NUNewsIndustry

 Meta Plans to Launch Smartwatch With Camera - NUNewsIndustry

[adityarana1687-blog]

Immunoassay Instruments Market To Surge Beyond $23.3 Billion By 2024

The global immunoassay instruments/analyzers market was valued at USD 14.7 billion in 2015 and is expected to reach a value of USD 23.3 billion by 2024. The prime factors driving the immunoassay analyzers market growth include constant introduction of advanced products. In addition, growing clinical applications for investigation and diagnosis of various chronic and related infectious diseases is expected to drive the growth of the immunoassay instruments market.

The industry is rapidly growing due to the constant introduction and adoption of automated as well as advanced techniques for laboratory instruments and analyzers in developed countries. Rising prevalence of infectious diseases and chronic conditions, which require early diagnosis, prevention, and treatment, is one of the main factors boosting the demand for immunoassay analyzers and compact consumable products in the healthcare sector. In addition, industry is gaining speed with the launch of innovative products such as compact and portable ichroma II of Boditech Med, Inc., which is an FDA-approved fluorescence scanning instrument. Moreover, with the U.S. FDA approval of the iStat cardiac Troponin I test cartridge that uses enzyme-linked immunosorbant assay (ELISA) method, commercialization of such immunoassay products is also expected to increase significantly over the next few years.

In North America, the government authorities and private companies have significantly contributed toward development of technology, supported research funding, and helped in commercialization of immunoassay analyzers and associated instruments. For instance, in June 2016, Abbott diagnostic launched Architect i1000SR, an automated immunoassay instrument that works on the principle of chemiluminescence. Using this system, number of different assays can be performed in a very short time.

Request a free sample copy or view report summary: Immunoassay Instruments/Analyzers Market Report

Immunoassay Instruments/Analyzers Market Report Highlights

Rapid adoption of advanced technology and automation of laboratory work flow, laboratory instruments, and analyzers is expected to fuel the market growth with CAGR of around 5% over the forecast period.

Consumables segment was the largest revenue generating space with over 70% market share in 2015. Repeated purchase of consumables and portable point-of-care kits have contributed to its growth, thus capturing the largest revenue share.

In 2015, North America captured the largest revenue share of around 37% of the global market. The continuous research on treatment of infectious diseases and subsequent grants from government healthcare agencies are contributing toward the development of a potential market for the expansion of immunoassay analyzers in the region.

Asia Pacific is expected to rise as the fastest growing region during the forecast period. The growing geriatric population in India, China, and Japan has led to the increase in the prevalence of infectious diseases, such as tuberculosis, cholera, typhoid, and various chronic conditions, such as cancer and autoimmune diseases, thereby promoting the utilization of immunoassays in the region.

The immunoassay instruments sector is dominated by a few key participants, such as Abbott Laboratories, bioMerieux, Inc. and Roche Diagnostics. Some of the other prominent players operating in the market include, but are not limited to, Becton Dickinson & Company; Diasorin S.p.A; Bio Rad Laboratories; and Siemen Healthcare GmbH. Introduction and adoption of automated systems and innovative designs is expected to intensify the competition by changing the industrial framework over the forecast period.

Immunoassay Instruments/Analyzers Market Segmentation

Grand View Research has segmented the immunoassay instruments/analyzers market by product, application, and region:

Immunoassay Instruments Market Product Outlook (Revenue in USD Million, 2013 - 2024)

Chemiluminescence immunoassay

Immunofluorescence analyzers

Radioimmunoassay

Enzyme-linked Immunoassay

Consumables

Immunoassay Instruments Market Application Outlook (Revenue in USD Million, 2013 - 2024)

Therapeutic drug monitoring

Oncology

Cardiology

Endocrinology

Infectious disease testing

Autoimmune disease

Immunoassay Instruments Market Regional Outlook (Revenue in USD Million, 2013 - 2024)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

U.S.

Canada

UK

Germany

Japan

China

Brazil

Mexico

South Africa

About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

[linhgd9]

Global Hypersensitive Troponin I Test Kit Industry Supply and Demand Analysis and Development Prospect Research Report by 2021-2026

GLOBAL INFO RESEARCH has made a brilliant attempt to elaborately and meticulously analyze the global Hypersensitive Troponin I Test Kit market in its latest report. All of the market forecasts presented in the report are authentic and reliable.

  The Hypersensitive Troponin I Test Kit market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

  According to our latest research, the global Hypersensitive Troponin I Test Kit size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Hypersensitive Troponin I Test Kit market size is expected to grow at a CAGR of xx% for the next five years.

  Global Hypersensitive Troponin I Test Kit Market: Market segmentation

Hypersensitive Troponin I Test Kit market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

  Request Sample Report and Full Report TOC:

https://www.globalinforesearch.com/reports/518409/hypersensitive-troponin-i-test-kit

  Global Hypersensitive Troponin I Test Kit Market: Regional Segmentation

To understand the changing political scenario, analysts have regionally segmented the market. This gives an overview of the political and socio-economic status of the regions that is expected to impact the market dynamic.

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

  Top Players of Global Hypersensitive Troponin I Test Kit Market are Studied:

Easydiagnosis

Tellgen

Chivd

  Market Segment by Type,can be divided into:

Time-resolved Immunofluorescence

Chemiluminescence Immunoassay

  Market Segment by Applications, covers:

Hospital

Clinic

  The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Hypersensitive Troponin I Test Kit product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Hypersensitive Troponin I Test Kit, with price, sales, revenue and global market share of Hypersensitive Troponin I Test Kit from 2019 to 2021.

Chapter 3, the Hypersensitive Troponin I Test Kit competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Hypersensitive Troponin I Test Kit breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Hypersensitive Troponin I Test Kit market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Hypersensitive Troponin I Test Kit sales channel, distributors, customers, research findings and conclusion, appendix and data source.

  About Us:

GlobaI Info Research（GIR） is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.

  Contact US

Global Info Research

E-mail: report@globalinforesearch.com

Tel:  +86-17665052062     00852-58197708(HK)

Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG

  Website: http://www.globalinforesearch.com

  from NeighborWebSJ https://ift.tt/3fuecPB via IFTTT

from WordPress https://ift.tt/2V0GKZG via IFTTT

[healthcare-market]

Cardiac Biomarker Diagnostic Kits Market Detailed in New Research Report

Transparency Market Research (TMR) has published a new report titled, ‘Cardiac Biomarker Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global cardiac biomarker diagnostic kits market was valued at around US$ 2.2 Bn in 2018 and is projected to grow at a CAGR of 5.2% from 2019 to 2027

Overview

· Cardiac biomarkers are also called cardiac markers. In a condition when the heart is damaged or stressed, cardiac biomarkers (endogenous substances including enzymes, hormones, and proteins) are released into the blood.

· Generally, cardiac markers are used to diagnose heart attack and acute coronary syndrome (ACS) or conditions associated with insufficient blood flow to the heart. These markers are also utilized in the diagnosis and risk stratification of patients with chest pain.

· Among cardiac biomarker tests, troponin is the biomarker test of choice for detecting heart damage. The test is performed with a blood sample using a needle to draw blood from a vein in the hand or arm. Troponin is elevated within a few hours of heart damage and stays elevated up to two weeks.

· There are other established biomarkers, such as myoglobin (test used along with troponin for early detection of heart attack) and creatinine kinase isoenzymes (also called cardiac enzyme, which is linked with injury of heart muscle and detection of a second heart attack anticipated shortly after the first)

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62931

Rise in prevalence of cardiovascular diseases across the world to Drive Market

· Growing prevalence of cardiovascular diseases across the world is the major driver for the growth of global cardiac biomarker diagnostic kits market.

· For instance, the American Heart Association estimated that 121.5 million adults had cardiovascular diseases between 2013 and 2016

· Advancements in novel technologies and increasing government funding for cardiovascular disease treatment are some of the major factors responsible for the growth of global cardiac biomarker diagnostic kits market

· Moreover, early detection to track the heart condition and integration of cardiology & IT are also some of the major factors fuelling the growth of global cardiac biomarker diagnostic kits market

Troponin Test Kits Segment to Dominate Market

· Based on product, the global cardiac biomarker diagnostic kits market has been segmented into troponin test kits, CK-MB test kits, myoglobin test kits, BNP test kits, C-reactive Protein (hsCRP), and other biomarkers

· Troponin test kits segment is accounted for major market share in global cardiac biomarker diagnostic kits market in 2018

· Growth of troponin test kits segment can be ascribed to its prodigious specificity and ability to accurately detect the cardiac events of acute coronary syndrome (ACS).

Request a Sample of Cardiac Biomarker Diagnostic Kits Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=62931

Cardiac Heart Failure – Promising Application Segment

· In terms of application, the global cardiac biomarker diagnostic kits market has been divided into angina pectoris, myocardial infarction (MI), cardiac heart failure, and others

· Angina pectoris dominated the global market in 2018 and is projected to dominate by the end of 2027 due to high incidence rate of angina pectoris across the globe

· Cardiac heart failure is more lucrative segment during the forecast period which is growing with a higher CAGR during the same period of 2019-2027 owing to rise in number of patient cases for cardiac heart failure across the world

Request for Analysis of COVID19 Impact on Cardiac Biomarker Diagnostic Kits Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=62931

Pont-of-care testing Segment– Higher Growth Rate

· On the basis of testing, the global cardiac biomarker diagnostic kits market has been bifurcated into laboratory testing, and point-of-care testing

· Point-of-care testing is more promising segment which is expected to grow with higher CAGR during the forecast period.

· Easy accessibility of point-of-care testing, increase in preference for point-of-care testing, and new kits & assays being offered by market players for rapid tests are expected to drive the point-of-care testing segment during the forecast period.

Diagnostic Laboratory End-user Segment- Major Market Share

· Based on end-user, the global cardiac biomarker diagnostic kits market has been segmented into hospitals, clinics, and diagnostic laboratory

· Diagnostic laboratory segment dominated the global cardiac biomarker diagnostic kits market in 2018 due to rise in hospital admissions for dental procedures, favorable reimbursement scenario, and increase in number of advanced diagnostic laboratories in the last decade which has led to a higher number of diagnostic tests being performed at these settings

Buy now Cardiac Biomarker Diagnostic Kits Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=62931&ltype=S

North America to Dominate Global Market

· In terms of region, the global cardiac biomarker diagnostic kits market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

· North America accounted for major share of the global cardiac biomarker diagnostic kits market in 2018 due to higher cardiovascular disease patient population, significant average selling price of analyzers, rise in demand for technologically advanced diagnostic instruments with enhanced specificity and precision among cardiologist, and favorable coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures in the region

· For instance, an article published in the Medscape states that more than 9.8 million people in the U.S. experience symptoms of angina, annually, and more than 500,000 cases are registered every year

· The cardiac biomarker diagnostic kits market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be ascribed to growing aging population, developing health care infrastructure, large patient population, increase in funding and investment toward the development of cardiac analyzers, and surge in focus of both international and domestic players in the region.

Competitive Landscape

· The global cardiac biomarker diagnostic kits market is consolidated as few players hold major market share in global market. Key players include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers, bioMérieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., among other

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/technological-advancements-and-innovations-to-fuel-growth-of-soft-tissue-repair-market-from-2018-to-2026-tmr-301168624.html

https://www.prnewswire.com/news-releases/global-oral-contraceptive-pills-market-projected-to-expand-at-6-cagr-rising-number-of-unplanned-pregnancies-drives-market-demand-tmr-301171827.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com/

[bloghealthcom]

Các xét nghiệm phát hiện nhồi máu cơ tim Update 06/2021

Bài viết Các xét nghiệm phát hiện nhồi máu cơ tim Update 06/2021 được chia sẻ bởi website Blog-Health #bloghealth #suckhoe #lamdep #sinhly

Bài viết được tư vấn chuyên môn bởi Bác sĩ Nguyễn Văn Dương - Trung tâm Tim mạch - Bệnh viện Đa khoa Quốc tế Vinmec Central Park.

<!-- -->

Đưa ra chẩn đoán nhồi máu cơ tim sớm và chính xác rất quan trọng, điều này sẽ giúp bệnh nhân nhanh chóng được tiếp cận các phác đồ điều trị phù hợp, nhằm hạn chế tối đa các biến chứng nặng của nhồi máu cơ tim và giảm tỷ lệ tử vong. Để chẩn đoán chính xác, bác sĩ c���n dựa trên các triệu chứng lâm sàng kết hợp với các xét nghiệm nhồi máu cơ tim.

1. Nhồi máu cơ tim là gì?

Nhồi máu cơ tim là tình trạng cơ tim bị hoại tử do thiếu máu cục bộ, làm giải phóng các chất có trong tế bào cơ tim vào trong máu. Các dấu hiệu nhận biết nhồi máu cơ tim sẽ giúp cho bệnh nhân được cấp cứu kịp thời, còn các xét nghiệm sẽ giúp chẩn đoán chính xác bệnh nhân có bị nhồi máu cơ tim hay không và mức độ tổn thương như thế nào.

Do đó mọi người cần biết các dấu hiệu nhận biết nhồi máu cơ tim sớm. Các dấu hiệu cảnh báo nhồi máu cơ tim ở mỗi người sẽ có biểu hiện và mức độ khác nhau, bên cạnh đó các dấu hiệu cũng dễ nhầm lẫn với các bệnh khác như bệnh đường hô hấp, tình trạng suy nhược cơ thể. Tuy nhiên, các bệnh nhân nhồi máu cơ tim vẫn có những dấu hiệu chung, có hai dấu hiệu mà bệnh nhân nhồi máu cơ tim nào cũng có thể có, đó là:

Bệnh nhân đột nhiên cảm thấy mệt mỏi, cảm giác khó thở ngay cả khi làm những việc mà trước kia vẫn làm được bình thường.

Người bệnh cảm thấy bồn chồn, lo lắng, bất an.

Biểu hiện của cơn nhồi máu cơ tim

Ngoài ra, bệnh nhân có thể gặp một số triệu chứng sau:

Đau ngực trái có thể lan tỏa tới hàm, tới bờ trong cánh tay. Triệu chứng này đôi khi không điển hình, hoặc có người không có biểu hiện đau.

Chóng mặt, đau đầu.

Buồn nôn, nôn mửa, khó tiêu.

Rối loạn giấc ngủ.

Vã mồ hôi.

Rối loạn thị giác.

Tê ngứa ở bàn tay hoặc cánh tay, chán ăn.

Phụ nữ và nam giới sẽ có những dấu hiệu cảnh báo khác nhau như ở phụ nữ sẽ ít gặp triệu chứng đau ngực, nhưng các triệu chứng mệt mỏi, lo lắng, đau đầu, chóng mặt lại xuất hiện nhiều hơn.

Tuy nhiên, đây chỉ là những triệu chứng cảnh báo nhồi máu cơ tim, chứ không thể khẳng định bạn có bị nhồi máu cơ tim hay không. Để chẩn đoán xác định cần dựa vào các xét nghiệm phát hiện nhồi máu cơ tim.

2. Các xét nghiệm phát hiện nhồi máu cơ tim

2.1. Điện tâm đồ

Điện tâm đồ là một phương pháp cận lâm sàng rất có giá trị. Song nhiều khi điện tâm đồ không đặc hiệu và không rõ. Hình ảnh điện tâm đồ của bệnh nhân nhồi máu cơ tim sẽ có sự biến đổi như sau:

Đoạn ST chênh lên hoặc chênh xuống

Sóng T đảo ngược

Xuất hiện sóng Q mới

Hoặc block nhánh trái mới được phát hiện

2.2. Siêu âm tim

Siêu âm tim rất có giá trị trong chẩn đoán nhồi máu cơ tim, nó có thể giúp ta nhìn thấy những hình ảnh rối loạn vận động vùng liên quan đến vị trí nhồi máu như: huyết khối buồng tim, dịch màng tim,...

Đồng thời siêu âm tim cũng giúp đánh giá chức năng của tâm thất trái và các biến chứng cơ học của nhồi máu cơ tim như: hở van tim do đứt dây chằng, hay thủng vách tim gây thông liên thất.

ECG điện tâm đồ cho thấy các sóng có dấu hiệu bất thường

2.3. Chụp động mạch vành (Coronary Angiography)

Phương pháp chụp động mạch vành là tiêu chuẩn vàng cho phép khẳng định chắc chắn bệnh nhân có nhồi máu cơ tim. Sau khi chụp mạch vành và phát hiện vùng tắc động mạch gây nhồi máu cơ tim, các bác sĩ sẽ tiến hành đặt stent để tái thông dòng chảy mạch vành và cứu sống vùng cơ tim đang bị nhồi máu. Đây là thủ thuật xâm lấn tối thiểu và khá an toàn cho bệnh nhân.

2.4. Các xét nghiệm hóa sinh

Các xét nghiệm hóa sinh rất cần thiết và có giá trị cao trong việc chẩn đoán và theo dõi nhồi máu cơ tim. Cho đến nay có 3 thế hệ các xét nghiệm hóa sinh được áp dụng để chẩn đoán nhồi máu cơ tim đó là:

Thế hệ 1:

Creatin kinase (CK) toàn phần

Aspartat amino transferase (ASAT)

Alanin amino tranferase (ALAT)

Lactat dehydrogenase (LDH)

Thế hệ 2: CK-MB và Myoglobin

Thế hệ 3: Các protein đặc trưng của cơ tim (Troponin)

Các xét nghiệm này lại được chia thành 2 loại:

Các xét nghiệm enzyme và isoenzyme: CK, LDH, ASAT, ALAT, CK-MB,...

Các xét nghiệm protein: CK-MB mass, Myoglobin, Troponin T, Troponin I,...

Việc chẩn đoán và đánh giá mức độ nhồi máu cơ tim căn cứ vào động học của các chất này trong huyết tương:

Giải phóng ra khỏi tổ chức: lúc đầu giải phóng chậm, sau nhanh, kích thích ổ nhồi máu, nồng độ, độ hòa tan và nơi khu trú của các chất quyết định thời gian xuất hiện của chúng ở trong máu.

Khuếch tán vào máu: do vị trí của cơ tim không gần với lưới mao mạch cho nên thời gian kể từ khi tế bào bị tổn thương cho tới khi các chất xuất hiện trong máu phải mất hàng giờ.

Thải trừ ra khỏi máu: tốc độ thải trừ của các chất trên là khác nhau.

Máu ngoại vi được sử dụng làm xét nghiệm hóa sinh

2.4.1. Các xét nghiệm enzyme và isoenzyme

2.4.2. Các xét nghiệm protein

2.4.2.1. Myoglobin

Myoglobin là một protein có trong bào tương của cơ tim, ngoài ra nó cũng có trong cơ xương. Myoglobin có các đặc điểm sau:

Là protein chứa Hem gắn O2, có khối lượng phân tử là 17.800 Da, nó có vai trò vận chuyển và dự trữ oxy trong tế bào cơ.

Là protein bào tương, chiếm khoảng 2% toàn bộ protein tế bào.

Có khối lượng nhỏ, do đó khi có tổn thương nhồi máu cơ tim thì myoglobin sẽ sớm xuất hiện ở huyết thanh nên có thể sử dụng để chẩn đoán sớm.

Thời gian bán hủy nhanh, chỉ từ 10 - 20 phút.

Để xác định Myoglobin người ta sử dụng phương pháp miễn dịch sử dụng kỹ thuật điện hóa phát quang (electroluminescence).

Bình thường Myoglobin có nồng độ trong huyết tương < 70 - 110 mcg/L. Nồng độ Myoglobin trong huyết tương cũng phụ thuộc vào độ lọc cầu thận, khi lượng Myoglobin huyết tương tăng > 200 mcg/L sẽ xuất hiện Myoglobin niệu.

Xét nghiệm Myoglobin tăng sau nhồi máu cơ tim

Ý nghĩa lâm sàng của chỉ số xét nghiệm Myoglobin:

Nồng độ Myoglobin tăng rất sớm, khoảng 2 giờ sau khi nhồi máu cơ tim cấp, nhồi máu cơ tim thứ phát hoặc khi tưới máu lại thành công sau liệu pháp streptolysin.

Nồng độ Myoglobin trong huyết tương đạt cực đại sau 4 - 12 giờ, trở về bình thường sau 24 giờ.

Chỉ số này giúp chẩn đoán sớm nhồi máu cơ tim nhưng không đặc hiệu vì nó còn tăng trong các tổn thương cơ xương.

2.4.2.2. CK-MB mass

CK-MB mass là một isoenzym của CK, được cho là CK đặc hiệu cho tim.

CK-MB có thể được xác định bằng phương pháp miễn dịch sử dụng kỹ thuật enzyme, hóa phát quang, huỳnh quang, hoặc điện hóa phát quang. CK-MB được xác định bằng sự kết hợp của nó với các kháng thể đặc hiệu CK-B và CK-M hoặc với kháng thể đặc hiệu của CK-MB.

Có hai phương pháp xác định CK-MB đó là:

Phương pháp đo hoạt độ (UZ/L)

Phương pháp đo khối lượng (mg/mL): phương pháp này đặc hiệu hơn phương pháp đo hoạt độ.

Bình thường nồng độ CK-MB trong huyết tương là < 5,3 - 8 mcg/L, tùy theo test kit.

CK-MB có ý nghĩa lâm sàng như sau:

Nồng độ tăng 4-5 giờ sau cơn đau thắt ngực.

Đây là một xét nghiệm được sử dụng trong chẩn đoán nhồi máu cơ tim và tưới máu lại.

2.4.2.3. Troponin

Troponin là một phức hợp protein có hình cầu nằm trong các sợi mảnh của cơ tim, nó tham gia vào quá trình điều hòa sự co cơ tim. Phức hợp này gồm ba thành phần đó là Troponin C, Troponin T, Troponin I. Trong đó Troponin C gắn kết với canxi và nó có cả ở cơ tim và cơ xương, còn Troponin T và Troponin I là dạng đặc hiệu của cơ tim.

Khi cơ tim bị hoại tử, Troponin sẽ được phóng thích vào trong máu, do đó xét nghiệm phát hiện Troponin I hoặc T trong máu đóng vai trò quan trọng để chẩn đoán chính xác nhồi máu cơ tim.

Troponin I (cTnI)

Nồng độ troponin I trong huyết tương bình thường là < 0,1-0,2 μg/L.

Troponin nằm trong sợi mảnh của cơ tim

Ý nghĩa lâm sàng của chỉ số Troponin I:

Khi bị nhồi máu cơ tim:

Troponin I tăng cùng với Troponin T sau cơn đau 3-4 giờ và đạt giá trị cực đại ở 12 - 24 giờ, điều này còn phụ thuộc vào sự tái tưới máu của động mạch vành.

Độ nhạy của Troponin I giống Troponin T trong pha đầu của nhồi máu cơ tim cấp, tăng cùng với CK-MB, CK isoenzym, Myoglobin.

Troponin I chỉ có một đỉnh tăng ở pha đầu tiên.

Trong các bệnh tim khác:

Với bệnh nhân sau ghép tim nếu không có sự loại trừ quả tim gáp thì troponin I sẽ trở về bình thường rất nhanh, khoảng 2 - 3 tuần.

Cơn đau thắt ngực không ổn định: nồng độ troponin có liên quan đến biến chứng và tỷ lệ tử vong.

Troponin T (TnT)

Bình thường nồng độ Troponin T trong huyết tương < 0,03 ng/ml.

Ý nghĩa lâm sàng của chỉ số Troponin T:

Xét nghiệm Troponin T có độ nhạy 100% (10 giờ - 5 ngày).

Độ đặc hiệu lớn hơn CK-MB mang Myoglobin.

Chu kỳ bán hủy của troponin < 2 giờ.

Sau nhồi máu cơ tim, troponin T xuất hiện sớm trong huyết thanh, đạt giá trị cực đại thứ nhất ở ngày thứ 4 và sau đó giảm dần cho tới ngày 12, do đó có khả năng chẩn đoán trường hợp nhồi máu cơ tim đến muộn.

Troponin T nhạy cảm như CK-MB, Myoglobin ở giai đoạn sớm, khi vùng tổn thương được tái tưới máu thì troponin T huyết thanh sẽ có cực đại thứ hai ở giờ thứ 14. Chính vì vậy troponin T có khả năng giám sát tác dụng điều trị làm tan huyết khối.

Troponin T có thể đánh giá sơ bộ kích thước và mức độ nhồi máu cơ tim trên giá trị đo được ở ngày thứ 3 - 4 sau cơn đau.

Chẩn đoán xác định nhồi máu cơ tim khi TnT > 0,1ng/ml.

Chẩn đoán phân biệt nhồi máu cơ tim với chấn thương và các phẫu thuật khác, đặc biệt khi TnT tăng hằng định sau 3- 4 ngày chấn thương hoặc phẫu thuật.

Các xét nghiệm nhồi máu cơ tim cần được thực hiện tại cơ sở y tế uy tín

Hiện nay , tại Vinmec đang áp dụng xét nghiệm Troponin độ nhạy cao (Troponin high sensitive) trong chẩn đoán sớm nhồi máu cơ tim và đưa ra biện pháp điều trị sớm nhất có thể cho bệnh nhân.

Trên đây là các chỉ số xét nghiệm nhồi máu cơ tim, tùy thuộc vào tình trạng của từng bệnh nhân và điều kiện cơ sở vật chất của cơ sở y tế mà bác sĩ sẽ lựa chọn các xét nghiệm phù hợp để chẩn đoán nhồi máu cơ tim.

Bệnh viện Đa khoa Quốc tế Vinmec là một trong những bệnh viện không những đảm bảo chất lượng chuyên môn với đội ngũ y bác sĩ đầu ngành, hệ thống trang thiết bị công nghệ hiện đại mà còn nổi bật với dịch vụ khám, tư vấn và chữa bệnh toàn diện, chuyên nghiệp; không gian khám chữa bệnh văn minh, lịch sự, an toàn và tiệt trùng tối đa. Khách hàng khi chọn thực hiện các xét nghiệm tại đây có thể hoàn toàn yên tâm về đ�� chính xác của kết quả xét nghiệm.

Bác sĩ Nguyễn Văn Dương đã có nhiều năm kinh nghiệm trong chẩn đoán và điều trị bệnh lý nội khoa tim mạch và can thiệp tim mạch; Thực hiện các thăm dò chức năng không xâm lấn khác trong chẩn đoán và điều trị các bệnh lý tim mạch. Hiện là bác sĩ điều trị tại trung tâm tim mạch, bệnh viện Vinmec Central Park từ tháng 08/2017

Khách hàng có thể trực tiếp đến hệ thống Y tế Vinmec trên toàn quốc để thăm khám hoặc liên hệ hotline tại đây để được hỗ trợ.

XEM THÊM:

Bệnh cơ tim thiếu máu cục bộ nên ăn gì?

Nhồi máu cơ tim cấp: Nguyên nhân, triệu chứng, chẩn đoán và điều trị

Sốc tim trong nhồi máu cơ tim

<!--

Để được bác sĩ gọi điện tư vấn miễn phí về xét nghiệm, hãy để lại thông tin của bạn vào form dưới đây:

Nơi sinh sống

Hà Nội

Hanoi

Hồ Chí Minh

Ho Chi Minh City

Phú Quốc

Phu Quoc

Nha Trang

Nha Trang

Hạ Long

Ha Long

Hải Phòng

Hai Phong

Đà Nẵng

Da Nang

Nước ngoài

Đăng ký nhận tư vấn

-->

source https://blog-health.com/cac-xet-nghiem-phat-hien-nhoi-mau-co-tim/

[fostermarketarch]

Lateral Flow Assay Market Revenue - Due To Increase In Huge Demand In This Sector

The global Lateral Flow Assay market was valued at US$ xx million in the year 2019. The market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2027, with an estimated CAGR of xx% during the forecast period (2021-2027). The research study also includes exhaustive information about market dynamics such as drivers, restraints, opportunities, technological advancements, future            trends, supply chain analysis, patent landscape, pricing analysis, regulatory and reimbursement framework for precise market estimations and forecasts.

Additionally, the business intelligence study encompasses the COVID-19 scenario as follows:

·         Long-Term, Mid-Term, and Short-Term Impact of COVID-19

·         Pre- and Post-COVID-19 Scenario

·         Disruptions in the Supply Chain

Get Free PDF Brochure Of This Report @ https://www.fostermarketresearch.com/product/industry/7/319/Pdf%20Brochure/

Competitive Insights

Leading and emerging companies of the global Lateral Flow Assay market were identified based on their current offerings. Further, the Lateral Flow Assay industry is one of the most competitive industries, with the leading players actively competing against each other to gain a greater share in the industry. Some of the major companies in the Lateral Flow Assay market are: Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens AG, Danaher Corporation, bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., Hologic Inc., Qiagen NV, Quidel Corporation, and Merck KGaA, among others.

The competitive landscape of the Lateral Flow Assay industry exhibits an inclination towards emerging strategies including product launches, partnerships, collaborations and contracts, acquisitions, funding, and other developments to achieve the objectives faster.

Our reports fill up the gaps and provide you with all the detailed analysis of competitive companies involving:

·         Analyzing competitive strategies and techniques

·         Competitive positioning of key players

·         PORTER’s and SWOT analysis for competitive risk analysis

·         Competitive Share Analysis

·         Financial analysis of players to determine their withstand capacity

·         Analyzing their sales path and product study

For More Information Of This Report @ https://www.fostermarketresearch.com/product/industry/7/319/

Key Segments Covered in the global Lateral Flow Assay market report are:

·         By Product Type: (Kits & Reagents and Lateral Flow Readers (Digital/Mobile Readers and Benchtop Readers)

·         By Application: (Clinical Testing (Infectious Diseases Testing (Mosquito-borne Disease Testing, Influenza Testing, Sexually Transmitted Infection Testing, Hepatitis Testing, Tuberculosis Testing, and Other Infectious diseases), Cardiac Markers (Troponin I and T Testing, CK-MB Testing, BNP or NT-proBNP Testing, Myoglobin Testing, D-Dimer Testing, and Other Cardiac Marker Testing), Pregnancy & Fertility Testing (Pregnancy Testing and Fertility Testing), Cholesterol/Lipid Testing, Drugs of Abuse Testing, Other Clinical Tests), Veterinary Diagnostics, Drug Development & Quality Testing and Food Safety & Environmental Safety)

Regional Coverage:

The global Lateral Flow Assay market segregates into five regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America followed by Europe held the major share of the global market (in terms of value) in 2020. However, Asia-Pacific region exhibit highest CAGR (%) during the forecast period (2021-2027). Our research study further sub-divides regions into countries as follows:

·         North America - the U.S. and Canada

·         Europe - Germany, the U.K., France, Spain, Italy, Russia, and Rest-of-Europe

·         Asia-Pacific - China, India, Japan, South Korea, Australia, ASEAN, and Rest-of-Asia-Pacific

·         Latin America - Mexico, Brazil, and Rest-of-Latin America

·         Middle East and Africa - Gulf Cooperation Council (GCC) Countries, South Africa, Israel, and Rest-of-Middle East and Africa

Market Dynamics:

The rise in initiatives taken by the government to curb malaria is anticipated to fuel market growth. For instance, in 2019, on World Malaria Day, WHO partnered with RBM, African Union Commission, and other partner organizations to create and spread awareness on malarial diagnosis and prevention. Moreover, according to a report published by WHO, total funding for elimination and control of malaria reached an estimated USD 3.1 billion in 2017. Funding contributed by governments of endemic countries amounted to US$ 900 million, representing approximately 28% of the total funding. Therefore, an increase in investments from governments to control malaria is expected to drive demand for lateral flow assays during the forecast period.

Buy Now This Business Strategic Report To Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/7/319/

About Foster Market Research:

Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.

Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.

Contact Us:

1701 Royal Lane,

#1306, Dallas

Tx-75229

Phone: +1 469 4981929

Email:

support@fostermarketresearch.com

[healthcaremarketforecasters]

Cardiac Biomarkers Market is Anticipated to Witness Fastest Growth Owing to 2024

Jan 21, 2021: Industry Insights

The global cardiac biomarkers market size was estimated at USD 4.7 billion in 2015. Rising prevalence of cardiovascular diseases globally and escalating popularity of POC testing are some of the main factors contributing toward the market growth.

Cardiac biomarkers are the substances released in the bloodstream due to heart related damage and stress. as a result of insufficient blood supply to the heart. The detection of the biomarkers is used for the identification of various heart conditions such as, acute coronary syndrome, acute myocardial infarction, ischemia, congestive heart failure.

High prevalence of cardiovascular diseases worldwide has resulted into a significant growth in the cardiac biomarkers market. According to the WHO, about 17.5 million people globally suffer from some heart condition. The increasing preference to the use of the cardiac kits and more awareness among the people regarding the application of the cardiac biomarkers is expected to augment the market in the near future.

Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/cardiac-biomarker-market/request-sample

Type Insights

Based on the types, the cardiac biomarker market is classified into the troponin, creatinine- kinase MB, Natriuretic peptides- b-type Natriuretic peptide and N terminal pro b–type Natriuretic peptide, myoglobin, and others. Troponin tests are in large demand for the detection of the AMI with efficient diagnosis of cardiovascular disorders. This growing demand has resulted in tremendous market growth of this segment.

Natriuretic peptides held the second largest share in 2015. The increasing incidence of the cardiovascular disorders has led to the surge in demand of these products, further attributing to the growth of the segment.

Application Insights

Based on application, the market is segmented into ACS (acute coronary syndrome), AMI (acute myocardial infarction), and CHF (congestive heart failure). The cardiac biomarkers have major application in the diagnosis of ACS and thus, this segment accounted for largest revenue generating sector. According to American Heart Association (AHA), the Americans are estimated to spend around USD 150 billion for treating ACS posing a huge social and economic burden.

Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/cardiac-biomarker-market

Followed by ACS, myocardial infarction held the second largest market share in 2015. The increasing number of the geriatric population has led to the growth of the sector, in this segment, as the elderly population is more prone to cardiac-related ailments. In addition, the growing unhealthy, sedentary lifestyle and alcohol consumption has further augmented the chances of the heart problems, hence, boosting the cardiac biomarker market growth.

End User Insights

The end user segment is fragmented into two types namely, laboratory testing and point of testing (PoC). The laboratory testing held the largest revenue share in 2015. Increasing incidence and prevalence of heart-related diseases is expected to flourish the segment growth.

The PoC testing segment is projected to witness growth at the highest CAGR during the forecast period. The rising demand for the PoC segment has led to the growth of the segment. Moreover, the rising awareness in the developing countries regarding the use of PoC testing and its application in cardiac biomarkers has nurtured the market growth.

Regional Insights

The regional market considered in the cardiac biomarkers sector are North America, Europe, Asia Pacific, Latin America, and MEA. North America is estimated to account for the largest revenue share in 2015. The high prevalence of the cardiac disorders in the North America has boosted the application of cardiac biomarkers in North America. Moreover, the increasing popularity of the PoC testing has added to the growth of the market.

The Asia Pacific region is anticipated to witness fastest growth owing to large population base with target disease. The high prevalence of the cardiovascular diseases has augmented the cardiac biomarker products in the Asia Pacific region. The major emerging markets such as India and China attributes for the major growth in the cardiac biomarker segment in the Asia Pacific region.

Competitive Insights

The major players in the cardiac biomarker market include Roche Diagnostics; Siemens Healthcare; Alere, Inc.; Beckman Coulter, Inc.; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Becton, Dickinson and Company; bioMérieux SA; and Randox Laboratories Ltd.

The new product launches and increasing development in the products are major growth trends in the cardiac biomarker market. The rising demand for efficient and rapid diagnostics of cardiovascular diseases is the key contributing factor to the sector growth. Alere triage panel, manufactured by Alere, Inc., is a combination of three major biomarkers namely, CK-MB, myoglobin, and troponin I. The test is handy due to efficient detection of the cardiovascular disease and, being a combination product, there is a great demand for the test in the market.

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com

Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184

[researchreportinsight]

Cardiac Biomarkers Market Research: Growth Opportunities by Regions, Types, Applications & Forecast to 2024

31st December 2020 – The global cardiac biomarkers market size was estimated at USD 4.7 billion in 2015. Rising prevalence of cardiovascular diseases globally and escalating popularity of POC testing are some of the main factors contributing toward the market growth. Cardiac biomarkers are the substances released in the bloodstream due to heart related damage and stress. as a result of insufficient blood supply to the heart. The detection of the biomarkers is used for the identification of various heart conditions such as, acute coronary syndrome, acute myocardial infarction, ischemia, congestive heart failure.

High prevalence of cardiovascular diseases worldwide has resulted into a significant growth in the cardiac biomarkers market. According to the WHO, about 17.5 million people globally suffer from some heart condition. The increasing preference to the use of the cardiac kits and more awareness among the people regarding the application of the cardiac biomarkers is expected to augment the market in the near future.

Based on the types, the cardiac biomarker market is classified into the troponin, creatinine- kinase MB, Natriuretic peptides- b-type Natriuretic peptide and N terminal pro b–type Natriuretic peptide, myoglobin, and others. Troponin tests are in large demand for the detection of the AMI with efficient diagnosis of cardiovascular disorders. This growing demand has resulted in tremendous market growth of this segment. Natriuretic peptides held the second largest share in 2015. The increasing incidence of the cardiovascular disorders has led to the surge in demand of these products, further attributing to the growth of the segment.

Access Cardiac Biomarkers Market Report with TOC @ https://www.millioninsights.com/industry-reports/cardiac-biomarker-market

Based on application, the market is segmented into ACS (acute coronary syndrome), AMI (acute myocardial infarction), and CHF (congestive heart failure). The cardiac biomarkers have major application in the diagnosis of ACS and thus, this segment accounted for largest revenue generating sector. According to American Heart Association (AHA), the Americans are estimated to spend around USD 150 billion for treating ACS posing a huge social and economic burden. Followed by ACS, myocardial infarction held the second largest market share in 2015. The increasing number of the geriatric population has led to the growth of the sector, in this segment, as the elderly population is more prone to cardiac-related ailments. In addition, the growing unhealthy, sedentary lifestyle and alcohol consumption has further augmented the chances of the heart problems, hence, boosting the cardiac biomarker market growth.

The end user segment is fragmented into two types namely, laboratory testing and point of testing (PoC). The laboratory testing held the largest revenue share in 2015. Increasing incidence and prevalence of heart-related diseases is expected to flourish the segment growth. The PoC testing segment is projected to witness growth at the highest CAGR during the forecast period. The rising demand for the PoC segment has led to the growth of the segment. Moreover, the rising awareness in the developing countries regarding the use of PoC testing and its application in cardiac biomarkers has nurtured the market growth.

The regional market considered in the cardiac biomarkers sector is North America, Europe, Asia Pacific, Latin America, and MEA. North America is estimated to account for the largest revenue share in 2015. The high prevalence of the cardiac disorders in the North America has boosted the application of cardiac biomarkers in North America. Moreover, the increasing popularity of the PoC testing has added to the growth of the market. The Asia Pacific region is anticipated to witness fastest growth owing to large population base with target disease. The high prevalence of the cardiovascular diseases has augmented the cardiac biomarker products in the Asia Pacific region. The major emerging markets such as India and China attributes for the major growth in the cardiac biomarker segment in the Asia Pacific region.

The major players in the cardiac biomarker market include Roche Diagnostics; Siemens Healthcare; Alere, Inc.; Beckman Coulter, Inc.; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Becton, Dickinson and Company; bioMérieux SA; and Randox Laboratories Ltd. The new product launches and increasing development in the products are major growth trends in the cardiac biomarker market. The rising demand for efficient and rapid diagnostics of cardiovascular diseases is the key contributing factor to the sector growth. Alere triage panel, manufactured by Alere, Inc., is a combination of three major biomarkers namely, CK-MB, myoglobin, and troponin I. The test is handy due to efficient detection of the cardiovascular disease and, being a combination product, there is a great demand for the test in the market.

Request a Sample Copy of Cardiac Biomarkers Market Report @ https://www.millioninsights.com/industry-reports/cardiac-biomarker-market/request-sample

[globalmarketreports]

POC Cardiac Market 2020 - Size, Share and Forecast Report by 2027

Cardiac POC is called as Cardiac Point of care which used to diagnose patients. POC includes cholesterol and coagulation testing as well as brain Natriuretic peptide test and troponin. Cardiac Point of care help in detection of enzyme detection which is relapsed by during cardiac condition like lactate, and troponin.

Request Sample Copy of this Report @ https://qualiketresearch.com/request-sample/POC-Cardiac-Market/request-sample

Change in healthcare regulatory standards across the world and practitioner approach towards POC diagnostics is the key driving factor which is expected to boost the global POC cardiac market growth. Furthermore, Rise in government investments on development of healthcare infrastructure in order to facilitate advanced facilities will have the positive impact on market growth. Moreover, increase in incidences of chronic diseases will fuel the market growth. In addition to that, continuous technological advancements by key players expected to propel market growth during this forecast period.

Market Restraints

However, lack of skilled professionals is the major challenging factor which is expected to hamper the global POC cardiac market. Also, lack of healthcare infrastructure in developing countries will affect the market growth.

Market Key Players

Various key players are discussed in this report such as Abbott Laboratories, Medtronic Inc, Roche Diagnostics, Boston Scientific Corp., Alere Inc, and Others

Browse Full Research Report @ https://qualiketresearch.com/reports-details/POC-Cardiac-Market

Market Taxonomy

By Product Type                                                                                              

Cardiac Markers Test

Combinational Test Kits

Myoglobin Test

Brain Natriuretic Peptide (BNP) Test

Creatine Kinase MB isoenzyme (CK-MB) Test

Cardiac troponin Test

Analyzers

By End User

Hospitals

Research Laboratories

Ambulatory Surgical Centers

Diagnostic Laboratories

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

About Us:-

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

Contact Person:-

Vishal Thakur

Research Support Specialist

QualiKet Research

6060 N Central Expy #500, TX 75204, U.S.A

Email: sales@qualiketresearch.com

Website: https://qualiketresearch.com

[blogsmithelenablr]

Cardiac Enzymes Market Growth 2020-2026 Industry Status and Outlook

The market report study titled ‘Global Cardiac Enzymes Market Report’ published by Reports and Data offers in-depth and comprehensive research describing the scope of the market and market insights until 2026. The report will include details about potential opportunities, new projects, financial situations, constructive business strategies, and an outlook on the industry forecast. The report aims to provide an in-depth analysis of the market impacted by the current pandemic. The COID-19 crisis has dynamically changed the economic scenario on a global level. The report is updated with the latest COVID-19 incidence, economic landscape, and present and future impact of COVID-19 on the market.

The research report further studies the growth driving and restraining factors impacting the regional market and competitive landscape of the business sphere. The study also offers deeper insights into the challenges and hurdles the established companies and new entrants might face in the Cardiac Enzymes industry.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1423

Competitive Analysis of the Cardiac Enzymes Market:

The Cardiac Enzymes market is further segmented into key players operating in the Cardiac Enzymes industry. The major companies profiled in the report include Abbott Laboratories, Alere Inc. and Roche Diagnostics Corporation. The Cardiac Enzymes market offers a detailed analysis of the product portfolio, key trends, applications, and a thorough value chain analysis. The report further covers strategic initiatives taken by each player in order to gain a footing in the market and expand their global reach. This includes mergers and acquisitions, product launches, joint ventures, collaborations, government deals, partnerships, and others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1423

Market Segmentation:

Product Type (Revenue, USD Million; 2016–2026)

Brain Natriuretic Peptide (BNPs) or NT-proBNP

Ischemia Modified Albumin (IMA)

Myoglobin

Troponins (T and I)

Myocardial muscle Creatine Kinase (CK-MB)

Others

Location of Testing (Revenue, USD Million; 2016–2026)

Laboratory Testing

Point of Care Testing

Application (Revenue, USD Million; 2016–2026)

Myocardial Infarction

Congestive Heart Failure

Acute Coronary Syndrome

Atherosclerosis

Others

End User (Revenue, USD Million; 2016–2026)

Diagnostic Laboratories

Hospitals and Clinics

The segmentation section offers pivotal insights into revenue generated as well as volume estimations for each product type and application. The report also offers projections about the product or application segment expected to dominate the market in the coming years. It also highlights the trends of the market and offers a granular assessment of the supply chain.

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/cardiac-biomarkers-market

Regional Analysis:

The report analyzes the market spread across key regions of the world and offers an assessment of the regional market pertaining to the growth rate, sales channels, and revenue generation. Furthermore, the key regions are also assessed for production and consumption rate, import/export, revenue contribution, market share and size, and the market presence of the prominent players in each region.

Key regions analyzed in the report are:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Radical Highlights of the Report:

Valuable insights about the Global Cardiac Enzymes Market with regards to market size, market share, valuations, and growth rate

Provides an 8-year forecast for the years 2020-2026, considering 2017 and 2018 as historical years, 2019 as the base year, and 2026 as the forecast year

Extensive analysis of the technological advancements, government regulatory framework, along with recent R&D and product advancements

Growth analysis and projections until 2026

Statistical analysis of the prominent players of the market

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1423

Key Questions Answered by the Report:

What are the key driving factors of the Cardiac Enzymes industry?

Which segment and sub-segment are expected to show significant growth during the forecast period?

What will the market size and growth rate be throughout the forecast period?

Who are the prominent players of the Cardiac Enzymes industry?

What are the technological advancements and product developments taking place in the Cardiac Enzymes market?

Which region is expected to dominate the market in the coming years?

What are the key outcomes of the SWOT analysis and Porter’s Five Forces analysis?

What are the key risk factors and challenges the companies will face in the market?

What factors are expected to hinder the growth of the Cardiac Enzymes industry

Browse Related Reports –

Allergy Diagnostic Assay Kits Market Size, Share and Global Industry Demand, Outlook By Type, By Product, By Application, End User and Regional Forecast, 2020-2027

Helicobacter Pylori Diagnostics Market Size, Share, Industry Overview, By Vertical, By Industry Type, By Application Type, Technology Type, and Regional Forecast 2020-2027

Thank you for reading our report. The report can be customized based on regional segmentation and leading players. Kindly get in touch with us to know more, and our team will ensure the report is well suited to meet your requirements.